Skip to content

Study · Animal study (in vivo) · mouse · 1988

3 results

[Differentiation and a change in the sensitivity to antibrain serum of circulating colony-forming units under the action of thymic factors].

Popov BV, Lesnikov VA, Isaeva EN

Tsitologiia1 Aug 1988

PMID3206541 (opens in a new tab)PepBankPUB-03206541
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In thymectomized and normal mice, thymalin increased circulating colony-forming unit granulocytopoietic activity.

    In plain wordsIn mice, thymalin increased the granulocyte-forming activity of circulating colony-forming units.

    Peptide
    Thymalin
    Outcome
    IncreaseCirculating CFU granulocytopoietic activity
    Study

    mousen: not reported in source

    Thymectomized and normal mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A commercial thymus preparation thymalin increases the granulocytopoietic activity of the circulating CFU and decreases their sensitivity to RAMBS in thymectomized and normal animals.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In thymectomized and normal mice, thymalin decreased circulating colony-forming unit sensitivity to rabbit anti-mouse brain serum.

    In plain wordsIn mice, thymalin reduced circulating colony-forming unit sensitivity to rabbit anti-mouse brain serum.

    Peptide
    Thymalin
    Outcome
    DecreaseCirculating CFU sensitivity to RAMBS
    Study

    mousen: not reported in source

    Thymectomized and normal mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A commercial thymus preparation thymalin increases the granulocytopoietic activity of the circulating CFU and decreases their sensitivity to RAMBS in thymectomized and normal animals.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In thymalin-treated mice, circulating colony-forming unit differentiation remained unchanged after rabbit anti-mouse brain serum administration.

    In plain wordsIn mice treated with thymalin, circulating colony-forming unit differentiation remained unchanged after rabbit anti-mouse brain serum administration.

    Peptide
    Thymalin
    Outcome
    No significant changeCirculating CFU differentiation after RAMBS
    Study

    mousen: not reported in source

    Thymectomized and normal mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Differentiation of circulating CFU remains unchanged in thymalin-treated mice after RAMBS administration, while CFU erythroid activity of nontreated animals is lowered.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.